Oliver Bohnsack

3.4k total citations · 1 hit paper
12 papers, 2.4k citations indexed

About

Oliver Bohnsack is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Oliver Bohnsack has authored 12 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Oliver Bohnsack's work include Cancer Immunotherapy and Biomarkers (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Oliver Bohnsack is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Oliver Bohnsack collaborates with scholars based in United States, Germany and United Kingdom. Oliver Bohnsack's co-authors include Axel Hoos, Michael Binder, F. Stephen Hodi, Omid Hamid, Célèste Lebbé, Rachel Humphrey, Jedd D. Wolchok, Michele Maio, Geoffrey Nichol and Jeffrey S. Weber and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Annals of Oncology.

In The Last Decade

Oliver Bohnsack

11 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria

2009 2.3k citations Jedd D. Wolchok, Axel Hoos et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Oliver Bohnsack United States	5	2.0k	957	700	386	300	12	2.4k
Michael Binder Austria	7	2.1k 1.0×	966 1.0×	809 1.2×	433 1.1×	315 1.1×	14	2.9k
Elizabeth Stankevich United States	15	2.4k 1.2×	1.3k 1.4×	665 0.9×	416 1.1×	117 0.4×	39	2.9k
Theresa M. Salay United States	6	2.1k 1.0×	1.3k 1.4×	578 0.8×	484 1.3×	110 0.4×	6	2.7k
Ramy Ibrahim United States	24	2.0k 1.0×	1.2k 1.2×	462 0.7×	430 1.1×	136 0.5×	66	2.4k
Alice Pons United States	5	2.4k 1.2×	1.3k 1.4×	668 1.0×	411 1.1×	114 0.4×	8	2.8k
Alexandra Snyder United States	24	1.6k 0.8×	932 1.0×	630 0.9×	783 2.0×	462 1.5×	66	2.8k
Rachel E. Sanborn United States	25	2.8k 1.4×	1.1k 1.2×	1.3k 1.8×	751 1.9×	241 0.8×	154	3.7k
C. Lewanski United Kingdom	16	2.4k 1.2×	587 0.6×	1.7k 2.4×	354 0.9×	174 0.6×	41	3.0k
Alessandra Curioni‐Fontecedro Switzerland	24	909 0.4×	424 0.4×	722 1.0×	398 1.0×	237 0.8×	87	1.8k
Zbigniew Nowecki Poland	26	1.6k 0.8×	362 0.4×	1.1k 1.5×	510 1.3×	257 0.9×	118	2.7k

Countries citing papers authored by Oliver Bohnsack

Since Specialization

Citations

This map shows the geographic impact of Oliver Bohnsack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Bohnsack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Bohnsack more than expected).

Fields of papers citing papers by Oliver Bohnsack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Bohnsack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Bohnsack. The network helps show where Oliver Bohnsack may publish in the future.

Co-authorship network of co-authors of Oliver Bohnsack

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Bohnsack. A scholar is included among the top collaborators of Oliver Bohnsack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Bohnsack. Oliver Bohnsack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Manitz, Juliane, Sandra P. D’Angelo, Andrea B. Apolo, et al.. (2022). Comparison of tumor assessments using RECIST 1.1 and irRECIST, and association with overall survival. Journal for ImmunoTherapy of Cancer. 10(2). e003302–e003302. 24 indexed citations

Narang, Jayant, Surabhi Bajpai, Manish Sharma, et al.. (2022). Value of assessing liver enlargement as a group a parameter in chronic lymphocytic leukemia (CLL) clinical trials: Retrospective review of data from multiple trials for incidence of liver enlargement and impact on response assessment.. Journal of Clinical Oncology. 40(16_suppl). e19517–e19517.

Bohnsack, Oliver, et al.. (2020). 168P Response assessments in hepatocellular carcinoma: What are the best criteria to utilize? mRECIST or RECIST 1.1? A retrospective meta-analysis of multiple phase III trials. Annals of Oncology. 31. S1304–S1304. 1 indexed citations

Narang, Jayant, et al.. (2020). Comparison of response using mRECIST versus RECIST 1.1 Criteria in advanced hepatocellular carcinoma: A retrospective analysis of multicenter clinical trials.. Journal of Clinical Oncology. 38(15_suppl). 4595–4595. 1 indexed citations

Sharma, Manish, et al.. (2019). RDI as a method for reviewer performance monitoring in BICR setup for improving data quality.. Journal of Clinical Oncology. 37(15_suppl). e18082–e18082. 1 indexed citations

Narang, Jayant, et al.. (2019). Retrospective comparison of Cheson 2007 and Lugano classification criteria in independent review assessment of FDG-avid lymphomas.. Journal of Clinical Oncology. 37(15_suppl). e19015–e19015. 1 indexed citations

Bohnsack, Oliver, et al.. (2014). Adaptation and modification of the immune related response criteria (IRRC): IrRECIST.. Journal of Clinical Oncology. 32(15_suppl). e22121–e22121. 25 indexed citations

Bohnsack, Oliver, et al.. (2014). Adaptation of the Immune Related Response Criteria: Irrecist. Annals of Oncology. 25. iv369–iv369. 67 indexed citations

Bohnsack, Oliver, et al.. (2013). Challenges with the ODAC-proposed independent audit of site investigator assessments.. Journal of Clinical Oncology. 31(15_suppl). e22161–e22161. 1 indexed citations

10.

Gebauer, Bernhard, Oliver Bohnsack, & H. Rieß. (2011). Radiologische Evaluation des Tumoransprechens in onkologischen Therapiestudien (Tumor Response Evaluation). RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 183(8). 695–703. 5 indexed citations

11.

Wolchok, Jedd D., Axel Hoos, Steven O’Day, et al.. (2009). Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria. Clinical Cancer Research. 15(23). 7412–7420. 2308 indexed citations breakdown →

12.

Bohnsack, Oliver. (2005). Reduktion der Strahlenexposition bei CT-Fluoroskopie-gesteuerten Interventionen: Möglichkeiten und Grenzen einer segmentalen Röhrenabschaltung. Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact